Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Further data on Schering-Plough's orally active CCR5 inhibitor against HIV-1

April 27, 2004

Alovudine enters dose-finding phase IIa study in multiresistant HIV

April 22, 2004

IR-103 shows HIV-1 specific immunogenicity in mouse model

April 22, 2004

Phase I trial of TNF-alpha inhibitor in HAART-resistant AIDS patients

April 21, 2004

Traditional approval for Ziagen

April 21, 2004

Kureha presents new CCR5 antagonists for HIV and other viral infections

April 20, 2004

Positive results for phase II trial of ThGRF for HIV-related lipodystrophy

April 19, 2004

BlockAide/CR cleared to enter phase Ib/IIa trial

April 19, 2004

Fuzeon to be made available through U.S. pharmacies

April 16, 2004

Human growth hormone found effective against wasting in HIV patients receiving HAART

April 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...